Tfs Capital Boosted By $492,890 Its Suncoke Energy (SXC) Stake; Reata Pharmaceuticals Class A (RETA) Sellers Decreased By 10.24% Their Shorts

October 22, 2017 - By reb123z

Tfs Capital Llc increased Suncoke Energy Inc (SXC) stake by 209.03% reported in 2017Q2 SEC filing. Tfs Capital Llc acquired 49,289 shares as Suncoke Energy Inc (SXC)’s stock declined 13.61%. The Tfs Capital Llc holds 72,869 shares with $794,000 value, up from 23,580 last quarter. Suncoke Energy Inc now has $661.31M valuation. The stock increased 0.78% or $0.08 on October 20, reaching $10.28. About 445,490 shares traded or 19.86% up from the average. SunCoke Energy Inc (NYSE:SXC) has risen 59.81% since October 22, 2016 and is uptrending. It has outperformed by 43.11% the S&P500.

Reata Pharmaceuticals Class A (NASDAQ:RETA) had a decrease of 10.24% in short interest. RETA’s SI was 881,900 shares in October as released by FINRA. Its down 10.24% from 982,500 shares previously. With 171,400 avg volume, 5 days are for Reata Pharmaceuticals Class A (NASDAQ:RETA)’s short sellers to cover RETA’s short positions. The SI to Reata Pharmaceuticals Class A’s float is 8.37%. The stock increased 3.18% or $1.01 on October 20, reaching $32.8. About 81,839 shares traded. Reata Pharmaceuticals Inc (NASDAQ:RETA) has 0.00% since October 22, 2016 and is . It has underperformed by 16.70% the S&P500.

Since May 9, 2017, it had 1 insider purchase, and 0 sales for $80,800 activity. 10,000 shares were bought by Yeaw Gary P, worth $80,800 on Tuesday, May 9.

Tfs Capital Llc decreased American Software Inc (NASDAQ:AMSWA) stake by 36,572 shares to 32,086 valued at $330,000 in 2017Q2. It also reduced Taylor Morrison Home Corp (NYSE:TMHC) stake by 28,948 shares and now owns 43,689 shares. Telephone & Data Sys Inc (NYSE:TDS) was reduced too.

Investors sentiment decreased to 0.9 in Q2 2017. Its down 0.05, from 0.95 in 2017Q1. It fall, as 20 investors sold SXC shares while 52 reduced holdings. 18 funds opened positions while 47 raised stakes. 56.98 million shares or 6.88% less from 61.19 million shares in 2017Q1 were reported. The New York-based Bancorp Of Ny Mellon has invested 0% in SunCoke Energy Inc (NYSE:SXC). Alliancebernstein Lp owns 0% invested in SunCoke Energy Inc (NYSE:SXC) for 114,971 shares. Teachers Retirement Systems Of The State Of Kentucky invested in 0% or 22,393 shares. Creative Planning has 0% invested in SunCoke Energy Inc (NYSE:SXC). California-based Schwab Charles Mngmt has invested 0.01% in SunCoke Energy Inc (NYSE:SXC). Assetmark accumulated 625 shares. Clarivest Asset Mngmt Limited Liability Corporation invested 0.02% in SunCoke Energy Inc (NYSE:SXC). Parametric Portfolio Associates Llc has invested 0% in SunCoke Energy Inc (NYSE:SXC). Ameriprise holds 0% in SunCoke Energy Inc (NYSE:SXC) or 622,114 shares. Parkside Fincl Bank And Tru invested in 0.01% or 2,217 shares. Valley National Advisers Inc accumulated 5 shares. Prudential Fincl holds 0.01% in SunCoke Energy Inc (NYSE:SXC) or 420,550 shares. State Board Of Administration Of Florida Retirement Sys holds 0% or 62,562 shares. Jhl Capital Grp Lc stated it has 150,000 shares. Renaissance Techs Ltd Liability Co has invested 0.03% in SunCoke Energy Inc (NYSE:SXC).

Among 4 analysts covering SunCoke Energy (NYSE:SXC), 2 have Buy rating, 2 Sell and 0 Hold. Therefore 50% are positive. SunCoke Energy had 6 analyst reports since July 22, 2015 according to SRatingsIntel. The firm has “Outperform” rating given on Friday, September 18 by FBR Capital. The rating was downgraded by Bank of America to “Underperform” on Wednesday, December 9. As per Friday, October 16, the company rating was downgraded by TheStreet. The firm has “Outperform” rating by FBR Capital given on Friday, October 21.

Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The company has market cap of $856.19 million. The Firm is focused on identifying, developing and commercializing product candidates that modulate the activity of regulatory proteins involved in the biology of mitochondrial function, oxidative stress, and inflammation to address the unmet medical needs of patients with a range of serious or life-threatening diseases. It currently has negative earnings.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.